PRO-LAD
| Clinical data | |
|---|---|
| Other names | 6-Propyl-6-nor-LSD; 6-Propyl-6-norlysergic acid diethylamide; N,N-Diethyl-6-propyl-9,10-didehydroergoline-8β-carboxamide |
| Routes of administration | Oral |
| Drug class | Serotonin receptor modulator; Serotonergic psychedelic; Hallucinogen |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C22H29N3O |
| Molar mass | 351.494 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
PRO-LAD, also known as 6-propyl-6-nor-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).